|
|
Post by lakers on Oct 6, 2019 14:40:13 GMT -5
|
|
|
|
Post by mannmade on Oct 6, 2019 14:54:07 GMT -5
Nice and succint! Good article!
|
|
|
|
Post by sayhey24 on Oct 6, 2019 18:59:09 GMT -5
Good Grief Mr. Harmel - "with type 2 diabetes, Afrezza could be a great add-on to basal insulin, especially for those who do not want any more injections"
If afrezza was used early in the diagnosis they would probably never need the basal. I will go as far as to say they may even see a regression in the diabetes.
|
|
|
|
Post by agedhippie on Oct 7, 2019 8:02:20 GMT -5
Good Grief Mr. Harmel - "with type 2 diabetes, Afrezza could be a great add-on to basal insulin, especially for those who do not want any more injections" If afrezza was used early in the diagnosis they would probably never need the basal. I will go as far as to say they may even see a regression in the diabetes. It's actually a good line. Basal is going to be the first insulin (and almost all the early use of insulin promoting regression papers I have seen use basal only), but here you have someone talking about using basal and Afrezza and not just basal. |
|
|
|
Post by mango on Oct 7, 2019 15:05:42 GMT -5
Even though it’s medically incorrect to use basal insulin in T2D since it’s a prandial insulin defect with loss of the FPIR, at least the words “great” and “Afrezza” are in the same sentence together, and Afrezza is getting some positive PR.
🤷🏻♂️
|
|
|
|
Post by mannmade on Oct 7, 2019 15:34:29 GMT -5
Even though it’s medically incorrect to use basal insulin in T2D since it’s a prandial insulin defect with loss of the FPIR, at least the words “great” and “Afrezza” are in the same sentence together, and Afrezza is getting some positive PR. 🤷🏻♂️ Agree and honestly I don't think I have yet seen the perfect Afrezza article by any outsider... Or even most insiders for that matter. |
|
|
|
Post by sayhey24 on Oct 7, 2019 17:57:01 GMT -5
Good Grief Mr. Harmel - "with type 2 diabetes, Afrezza could be a great add-on to basal insulin, especially for those who do not want any more injections" If afrezza was used early in the diagnosis they would probably never need the basal. I will go as far as to say they may even see a regression in the diabetes. It's actually a good line. Basal is going to be the first insulin (and almost all the early use of insulin promoting regression papers I have seen use basal only), but here you have someone talking about using basal and Afrezza and not just basal. Aged - you are correct, today the first insulin which most T2s will see will be a basal but thats anything but good. As Al Mann said thats medically incorrect. The first insulin and the first treatment T2s should get is afrezza. Can you imagine how all those regression papers would turn out if when first diagnosed T2s were taking afrezza and got their BGs back under 140 in short order? While those papers had good results with subq, with afrezza they would have had great results. Its just a matter of time before everyone has a CGM on their wrist. When that happens many will have a whistle in their pocket. |
|
